skip to content

Department of Oncology

 
Read more at: Giving the immune system a double boost against cancer

Giving the immune system a double boost against cancer

7 December 2020

Researchers from the University of Cambridge and Cold Spring Harbour Laboratory (CSHL) have completed an early phase clinical trial of a drug called plerixafor showing that it induces an integrated immune response in the tumours of patients with cancer types that do not usually respond to immunotherapy. The results...


Read more at: SORCE kidney cancer trial results published

SORCE kidney cancer trial results published

7 December 2020

Trial results, published in the Journal of Clinical Oncology by Professor Tim Eisen (Department of Oncology and CRUK Cambridge Centre Urological Malignancies Programme), have concluded that active observation remains the best care for kidney cancer patients after surgery. Over 1,700 patients participated in the double-...


Read more at: Raj Jena wins Best use of AI award at the Health Tech Awards 2020

Raj Jena wins Best use of AI award at the Health Tech Awards 2020

7 December 2020

Dr Raj Jena (Department of Oncology, Consultant oncologist and CRUK Cambridge Centre Neuro-Oncology Programme and RadNet) and the InnerEye team at Microsoft Research have won the Best use of AI award at the Health Tech Awards 2020 for innovative use of technology to speed up radiotherapy for cancer patients. A machine...


Read more at: New test to transform oesophageal cancer diagnosis

New test to transform oesophageal cancer diagnosis

5 August 2020

‘Sponge on a string’ test to transform oesophageal cancer diagnosis A ‘sponge on a string’ pill test has been hailed a ‘game-changer’ by Cambridge cancer doctors after results from a hugely successful 3 year trial were published in the medical journal published in The Lancet on 31 July 2020. The trial results for the...


Read more at: New online tool to analyse complex cancer patient data

New online tool to analyse complex cancer patient data

5 August 2020

New online tool to analyse complex cancer patient data A new clinical decision-making tool has been developed for patients on a trial offering personalised cancer treatment. Cambridge is one of seven leading cancer centres across Europe that constitute Cancer Core Europe collaborating on a new type of clinical trial...


Read more at: The CRUK Open Lab Initiative

The CRUK Open Lab Initiative

5 August 2020

Connecting cancer researchers across the UK The CRUK Open Lab Initiative connects cancer researchers using an online ‘matchmaking’ platform, rather like a dating website. Research groups with mutual or complementary interests and expertise are matched together to spark creative discussions, generate novel scientific ideas...


Read more at: LinkedIn Learning at Cambridge Hub

LinkedIn Learning at Cambridge Hub

28 May 2020

What is LinkedIn Learning at Cambridge? LinkedIn Learning is an online learning resource available for the staff and students of the University of Cambridge and its colleges. Key benefits The learning resource can provide useful material for staff and students who are working and studying from home. It can be used to...


Read more at: Revised clinical guidelines for treating cancer patients during COVID-19 pandemic

Revised clinical guidelines for treating cancer patients during COVID-19 pandemic

20 April 2020

Professor Richard Gilbertson (Head of Department of Oncology and Director of CRUK Cambridge Centre) would like to bring to your attention an important paper recently published in Nature Medicine, co-authored by Carlos Caldas (Department of Oncology), . Cambridge and six other leading cancer centres across Europe have...


Read more at: Predicting cancer risk through studying mutations in blood

Predicting cancer risk through studying mutations in blood

20 April 2020

Cancer is evolution at the cellular level. As we age, we acquire mutations in the cells that make up our tissues. Whilst the vast majority of these mutations are harmless, some of them can increase the risk of developing cancer. In research recently published in Science Jamie Blundell's Group (Department of Oncology)...


Read more at: Cambridge in top 20 cancer centres in Europe

Cambridge in top 20 cancer centres in Europe

20 April 2020

Many congratulations to the Cancer Research UK Cambridge Centre, led by Professor Richard Gilbertson, which has been re-accredited as a Comprehensive Cancer Centre by the Organisation of European Cancer Institutes (OECI) for a further five years. This is a prestigious designation which is only given to the top 20 Cancer...